Lampalizumab (Anti-Complement Factor D)
Product Specifications
CAS Number
1278466-20-8
Synonyms
RG 7417; TNX 234; Anti-CFD Recombinant Antibody
Additionnal Information
Lampalizumab (Anti-Complement Factor D) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6932704 1.0 µg DNA
Dync1h1 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details 
bs-18822R-BF405 100 µL
MEX3D/RNF193 Polyclonal Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details